{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T06:37:46Z","timestamp":1781419066952,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.vaccine.2014.08.070","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T17:28:38Z","timestamp":1410802118000},"page":"6138-6145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination"],"prefix":"10.1016","volume":"32","author":[{"given":"Josianne Nitcheu","family":"Tefit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Crab\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Orlandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haylene","family":"Nell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Bendelac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglou","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Teyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.08.070_bib0005","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/ni.2143","article-title":"Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals","volume":"12","author":"Brennan","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0010","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1172\/JCI62267","article-title":"Scavenger receptors target glycolipids for natural killer T cell activation","volume":"122","author":"Freigang","year":"2012","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2567.2012.03612.x","article-title":"Turned on by danger: activation of CD1d-restricted invariant natural killer T cells","volume":"137","author":"Lawson","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jim.2006.02.009","article-title":"A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells","volume":"312","author":"Liu","year":"2006","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0025","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1021\/ol025565+","article-title":"Synthesis and NKT cell stimulating properties of fluorophore- and biotin-appended 6\u201d-amino-6\u201d-deoxy-galactosylceramides","volume":"4","author":"Zhou","year":"2002","journal-title":"Organ Lett"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0030","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1586\/14760584.7.10.1519","article-title":"Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants","volume":"7","author":"Kim","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0035","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1073\/pnas.040566697","article-title":"Critical contribution of liver natural killer T cells to a murine model of hepatitis","volume":"97","author":"Takeda","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0040","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1073\/pnas.1833166100","article-title":"The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion","volume":"100","author":"Wilson","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0045","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1172\/JCI24762","article-title":"Glycolipid antigen induces long-term natural killer T cell anergy in mice","volume":"115","author":"Parekh","year":"2005","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0050","first-page":"3702","article-title":"A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors","volume":"8","author":"Giaccone","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0055","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1084\/jem.20042592","article-title":"Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients","volume":"201","author":"Chang","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0060","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1158\/1078-0432.CCR-04-1453","article-title":"A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer","volume":"11","author":"Ishikawa","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood-2003-04-1155","article-title":"Therapeutic activation of Valpha24+Vbeta11+NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity","volume":"103","author":"Nieda","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0070","doi-asserted-by":"crossref","first-page":"320","DOI":"10.14573\/altex.2007.4.320","article-title":"Animal experiments scrutinised: systematic reviews demonstrate poor human clinical and toxicological utility","volume":"24","author":"Knight","year":"2007","journal-title":"ALTEX"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0075","doi-asserted-by":"crossref","first-page":"206","DOI":"10.7150\/ijms.5529","article-title":"Systematic reviews of animal models: methodology versus epistemology","volume":"10","author":"Greek","year":"2013","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1194\/jlr.M019927","article-title":"Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia","volume":"53","author":"Yin","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molimm.2012.10.016","article-title":"Transport and uptake of immunogenic lipids","volume":"55","author":"Freigang","year":"2013","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0090","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.4049\/jimmunol.163.9.4647","article-title":"Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells","volume":"163","author":"Carnaud","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0095","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1172\/JCI40451","article-title":"Fatty acid amide hydrolase shapes NKT cell responses by influencing the serum transport of lipid antigen in mice","volume":"120","author":"Freigang","year":"2010","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2014.08.070_bib0100","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20102630","article-title":"PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions","volume":"208","author":"Thomas","year":"2011","journal-title":"J Exp Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14012286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14012286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T15:10:26Z","timestamp":1689520226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14012286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":20,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0264410X14012286"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.070","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}